Assessing key model parameters for economic evaluation of pandemic influenza interventions: the data source matters. Naiyana Praditsitthikorn,a,b Surachai Kotirum,a Adun Mohara,a Kuntika Dumrongprat,a Roman Perez Velasco,c Yot Teerawattananona aHealth Intervention and Technology Assessment P

This study marks Thailand’s first application of Distributional Cost-Effectiveness Analysis (DCEA), demonstrating that the concept of “equity” can be incorporated into economic evaluation. The analysis examines dialysis options, namely peritoneal dialysis (PD) and hemodialysis (HD), for patients

Recognizing the benefits of economic evaluations as a tool to inform public health policy, the Bill and Melinda Gates Foundation (BMGF) in collaboration with the Tufts Medical Center has endeavored to aid in creating the tools, mechanisms, and frameworks to facilitate the generation of research, assessments, and evaluations globally. While the conc

Presently, Cost-Effectiveness Analysis has been increasingly adopted in health technology assessment. In addition, it is recognized as an important tool for policy makers in the health care resource allocation decision making process. However, the presentation of Cost-Effectiveness Analysis results in terms of cost per Quality-Adjusted Life Year (Q

If we raise the word “addiction” to you, what are the things you are thinking of? Ecstasy? Methamphetamine? Cannabis? That is true. Addiction normally refers to drug addiction or substances that we take into our body and cause desire to retake it again. Addiction also harms both physical and mental

Sitaporn Youngkong MSc, PhD* * Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand This article provides an overview of the potential uses of health technology assessment (HTA) in health technology or health intervention-related policy decision-

Apirujee Punjataewakupt, PhD, earned her doctoral degree in pharmaceutical sciences from Chulalongkorn University. She has diverse experience in both the pharmaceutical industry and health-related research. She is currently serving as a research assistant at the Health Intervention and Technology Assessment Program (HITAP).Her expertise includes ph

AMR occurs when pathogens (bacteria, viruses, fungi and parasites) develop a resistance or tolerance to the medicines that are used to combat these microorganisms, such that these treatments are no longer effective. AMR is a natural phenomenon, however the speed at which it occurs is impacted by how

EXECUTIVE SUMMARY This annual report has been prepared to compile and summarise the activities of the Health Intervention and Technology Assessment Program (HITAP) projects in the past year (2023). It highlights various initiatives aligned with HITAP’s vision, mission, and strategic pillars, guid

EXECUTIVE SUMMARY This annual report has been prepared to compile and summarise the activities of the Health Intervention and Technology Assessment Program (HITAP) projects in the past year (2023). It highlights various initiatives aligned with HITAP’s vision, mission, and strategic pillars, guid